Related Experiment Video
Updated: Aug 8, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity
1Department of Genetics, Durham, NC 27710, USA.
Abstract:
In complex with the immunophilin FKBP12, the natural product rapamycin inhibits signal transduction events required for G1 to S phase cell cycle progression in yeast and mammalian cells. Genetic studies in yeast first implicated the TOR1 and TOR2 proteins as targets of the FKBP12-rapamycin complex. We report here that the TOR2 protein is membrane associated and localized to the surface of the yeast vacuole. Immunoprecipitated TOR2 protein contains readily detectable phosphatidylinositol-4 (PI-4) kinase activity attributable to either a TOR2 intrinsic activity or to a PI-4 kinase tightly associated with TOR2. Importantly, we find that rapamycin stimulates FKBP12 binding to wild-type TOR2 but not to a rapamycin-resistant TOR2-1 mutant protein. Surprisingly, FKBP12-rapamycin binding does not markedly inhibit the PI kinase activity associated with TOR2, but does cause a delocalization of TOR2 from the vacuolar surface, which may deprive the TOR2-associated PI-4 kinase activity of its in vivo substrate. Several additional findings indicate that vacuolar localization is important for TOR2 function and, conversely, that TOR2 modulates vacuolar morphology and segregation. These studies demonstrate that TOR2 is an essential, highly conserved component of a signal transduction pathway regulating cell cycle progression conserved from yeast to man.
Insights
Rapamycin, in complex with FKBP12, targets TOR2, a yeast vacuole-associated protein kinase. This interaction delocalizes TOR2, impacting cell cycle progression and vacuolar function, revealing a conserved signaling pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Rapamycin inhibits cell cycle progression by targeting FKBP12-rapamycin complexes.
- Genetic studies implicated TOR1 and TOR2 proteins as targets of FKBP12-rapamycin.
- TOR2's role in cell cycle regulation and its localization were previously unclear.
Purpose of the Study:
- To investigate the localization and function of the TOR2 protein in yeast.
- To determine the effect of the FKBP12-rapamycin complex on TOR2 activity and localization.
- To elucidate the role of TOR2 in cell cycle progression and vacuolar dynamics.
Main Methods:
- Immunoprecipitation of TOR2 protein.
- Assay of phosphatidylinositol-4 (PI-4) kinase activity associated with TOR2.
- Analysis of FKBP12 binding to wild-type and mutant TOR2 in the presence of rapamycin.
- Microscopy to assess TOR2 localization and vacuolar morphology.
Main Results:
- TOR2 protein is membrane-associated and localized to the yeast vacuole surface.
- Immunoprecipitated TOR2 exhibits PI-4 kinase activity.
- Rapamycin stimulates FKBP12 binding to wild-type TOR2, causing its delocalization from the vacuole.
- Delocalization, not inhibition of kinase activity, appears to be the key consequence of rapamycin binding.
- TOR2 localization is crucial for its function and influences vacuolar morphology.
Conclusions:
- TOR2 is an essential, conserved protein involved in cell cycle regulation.
- Vacuolar localization of TOR2 is critical for its function in signal transduction.
- Rapamycin-mediated delocalization of TOR2 from the vacuole disrupts its signaling pathway.
- TOR2 plays a role in modulating vacuolar morphology and segregation.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways

